Sakamoto M, Ueno T, Nakamura T, Sakata R, Hasimoto O, Torimura T, Sata M
Second Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume 830-0011, Japan.
Eur J Clin Invest. 2005 Mar;35(3):220-5. doi: 10.1111/j.1365-2362.2005.01476.x.
In this study, we investigated the effects of oestrogen on nitric oxide synthase activity and nitric oxide production using the cirrhotic rat liver.
Cirrhosis was induced by dimethylnitrosamine. Estradiol valerate was subcutaneously injected twice at week 4 after dimethylnitrosamine treatment. Furthermore, subcutaneous injection of an oestrogen receptor antagonist, ICI-182.780, was performed 2 days before administration of estradiol valerate. Portal pressure and hepatic blood flow were measured. Nitric oxide synthase activity was assessed by l-citrulline generation. Sinusoidal endothelial cells were isolated from the cirrhotic rat liver and cultured. The cells were incubated with estradiol and/or ICI-182.780 for 24 h. Images for nitric oxide in sinusoidal endothelial cells were obtained using diaminofluorescein-2 diacetate.
Cirrhotic rats treated with estradiol valerate showed a significant decrease in portal pressure and a significant increase in hepatic blood flow compared with those of control cirrhosis rats. However, in cirrhotic rats treated with ICI-182.780, the reduction of portal pressure and elevation of hepatic blood flow were completely inhibited. In cirrhotic rats treated with estradiol valerate, nitric oxide synthase activity was increased compared with that in control cirrhotic rats. The fluorescent level of intracellular nitric oxide in estradiol-stimulated, cultured, sinusoidal endothelial cells was higher than that in nontreated sinusoidal endothelial cells.
The present study indicated that oestrogen plays an important role in the enhancement of nitric oxide production in sinusoidal endothelial cells of cirrhotic liver and reduces the portal pressure in cirrhotic rats.
在本研究中,我们使用肝硬化大鼠肝脏研究了雌激素对一氧化氮合酶活性和一氧化氮生成的影响。
用二甲基亚硝胺诱导肝硬化。在二甲基亚硝胺处理后第4周,皮下注射两次戊酸雌二醇。此外,在给予戊酸雌二醇前2天皮下注射雌激素受体拮抗剂ICI-182.780。测量门静脉压力和肝血流量。通过L-瓜氨酸生成评估一氧化氮合酶活性。从肝硬化大鼠肝脏分离并培养肝窦内皮细胞。将细胞与雌二醇和/或ICI-182.780孵育24小时。使用二氨基荧光素-2二乙酸酯获取肝窦内皮细胞中一氧化氮的图像。
与对照肝硬化大鼠相比,戊酸雌二醇处理的肝硬化大鼠门静脉压力显著降低,肝血流量显著增加。然而,在接受ICI-182.780治疗的肝硬化大鼠中,门静脉压力的降低和肝血流量的升高被完全抑制。与对照肝硬化大鼠相比,戊酸雌二醇处理的肝硬化大鼠一氧化氮合酶活性增加。在雌二醇刺激的培养肝窦内皮细胞中,细胞内一氧化氮的荧光水平高于未处理的肝窦内皮细胞。
本研究表明,雌激素在增强肝硬化肝脏肝窦内皮细胞一氧化氮生成中起重要作用,并降低肝硬化大鼠的门静脉压力。